Establishment of a human meibomian gland carcinoma cell model and analysis of differently expressed genes.

[1]  Yanjin He,et al.  MicroRNA-3907 promotes the proliferation and migration of sebaceous gland carcinoma of the eyelid by targeting thrombospondin 1 , 2021, Oncology Letters.

[2]  Sander R. Dubovy,et al.  Establishment and Characterization of a Novel Human Ocular Adnexal Sebaceous Carcinoma Cell Line , 2021, Translational vision science & technology.

[3]  Juan Ye,et al.  Clinicopathological analysis of 5146 eyelid tumours and tumour-like lesions in an eye centre in South China, 2000–2018: a retrospective cohort study , 2021, BMJ Open.

[4]  A. Borczuk,et al.  Genomic Underpinnings of Tumor Behavior in in situ and Early Lung Adenocarcinoma. , 2019, American journal of respiratory and critical care medicine.

[5]  Y. Tabuchi,et al.  CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid , 2019, International Ophthalmology.

[6]  M. V. Cicinelli,et al.  Ocular sebaceous gland carcinoma: an update of the literature , 2019, International Ophthalmology.

[7]  V. Singh,et al.  Vimentin overexpression as a novel poor prognostic biomarker in eyelid sebaceous gland carcinoma , 2019, British Journal of Ophthalmology.

[8]  Thanet Sophonnithiprasert,et al.  GSTM1 and GSTT1 copy number variants and the risk to Thai females of hepatocellular carcinoma. , 2019, Journal of gastrointestinal oncology.

[9]  D. Radisky,et al.  PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma , 2019, Scientific Reports.

[10]  Xianqun Fan,et al.  Identification and regulation pattern analysis of long noncoding RNAs in meibomian gland carcinoma. , 2019, Epigenomics.

[11]  Haiyang Xie,et al.  Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma , 2018, BMB reports.

[12]  Charles J. Vaske,et al.  Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma , 2018, Nature Communications.

[13]  D. Ogata,et al.  Dermoscopic features of ocular and extraocular sebaceous carcinomas , 2017, The Journal of dermatology.

[14]  T. Pekmezović,et al.  GSTM1 genotype is an independent prognostic factor in clear cell renal cell carcinoma. , 2017, Urologic oncology.

[15]  Prahlad T. Ram,et al.  Next‐generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma , 2016, The Journal of pathology.

[16]  R. F. Lam,et al.  Muir-Torre Syndrome in a Middle-Aged Chinese Patient with Sebaceous Carcinoma of the Eyelid , 2015, Seminars in ophthalmology.

[17]  Yanjin He,et al.  Establishment and characterization of a cell line from human adenoid cystic carcinoma of the lacrimal glands and a nude mouse transplantable model. , 2015, Oncology reports.

[18]  Hong-yan Cheng,et al.  PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer. , 2015, Gynecologic oncology.

[19]  S. Kaliki,et al.  Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians , 2015, Eye.

[20]  V. White,et al.  Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor). , 2014, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[21]  F. Ishikawa,et al.  Human cancer growth and therapy in immunodeficient mouse models. , 2014, Cold Spring Harbor protocols.

[22]  Edward L. Huttlin,et al.  Candidate serum biomarkers for early intestinal cancer using 15N metabolic labeling and quantitative proteomics in the ApcMin/+ mouse. , 2013, Journal of proteome research.

[23]  S. Walters,et al.  Observational prospective cohort study of patients with newly-diagnosed ocular sebaceous carcinoma , 2012, British Journal of Ophthalmology.

[24]  B. Esmaeli,et al.  American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival. , 2012, Ophthalmology.

[25]  S. Arase,et al.  Immunohistochemical findings of sebaceous carcinoma and sebaceoma: Retrieval of cytokeratin expression by a panel of anti‐cytokeratin monoclonal antibodies , 2011, The Journal of dermatology.

[26]  Man Li,et al.  [Preliminary study on the establishment of the animal model and biological activity of human being meibomian gland carcinoma]. , 2011, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.

[27]  R. Shahsiah,et al.  Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma. , 2010, American journal of clinical pathology.

[28]  C. Shields,et al.  Sebaceous carcinoma of the eyelids: personal experience with 60 cases. , 2004, Ophthalmology.

[29]  Z. Gatalica,et al.  Loss of mismatch repair proteins in sebaceous gland tumors , 2003, Journal of cutaneous pathology.

[30]  H. Choung,et al.  Expression of cell cycle regulatory proteins in eyelid sebaceous gland carcinoma: low p27 expression predicts poor prognosis. , 2014, Experimental eye research.